TLR4-NOX4-AP-1 signaling mediates lipopolysaccharide-induced CXCR6 expression in human aortic smooth muscle cells

Devang N. Patel, Steven R Bailey, John K. Gresham, David B. Schuchman, James H. Shelhamer, Barry J. Goldstein, Brian M. Foxwell, Michael B. Stemerman, Jodi K. Maranchie, Anthony J. Valente, Srinivas Mummidi, Bysani Chandrasekar

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

CXCL16 is a transmembrane non-ELR CXC chemokine that signals via CXCR6 to induce aortic smooth muscle cell (ASMC) proliferation. While bacterial lipopolysaccharide (LPS) has been shown to stimulate CXCL16 expression in SMC, its effects on CXCR6 are not known. Here, we demonstrate that LPS upregulates CXCR6 mRNA, protein, and surface expression in human ASMC. Inhibition of TLR4 with neutralizing antibodies or specific siRNA interference blocked LPS-mediated CXCR6 expression. LPS stimulated both AP-1 (c-Fos, c-Jun) and NF-κB (p50 and p65) activation, but only inhibition of AP-1 attenuated LPS-induced CXCR6 expression. Using dominant negative expression vectors and siRNA interference, we demonstrate that LPS induces AP-1 activation via MyD88, TRAF6, ERK1/2, and JNK signaling pathways. Furthermore, the flavoprotein inhibitor diphenyleniodonium chloride significantly attenuated LPS-mediated AP-1-dependent CXCR6 expression, as did inhibition of NOX4 NADPH oxidase by siRNA. Finally, CXCR6 knockdown inhibited CXCL16-induced ASMC proliferation. These results demonstrate that LPS-TLR4-NOX4-AP-1 signaling can induce CXCR6 expression in ASMC, and suggest that the CXCL16-CXCR6 axis may be an important proinflammatory pathway in the pathogenesis of atherosclerosis.

Original languageEnglish (US)
Pages (from-to)1113-1120
Number of pages8
JournalBiochemical and Biophysical Research Communications
Volume347
Issue number4
DOIs
StatePublished - Sep 8 2006

Fingerprint

Transcription Factor AP-1
Smooth Muscle Myocytes
Lipopolysaccharides
Muscle
Cells
Small Interfering RNA
Cell proliferation
Chemical activation
TNF Receptor-Associated Factor 6
Cell Proliferation
CXC Chemokines
Flavoproteins
MAP Kinase Signaling System
NADPH Oxidase
Neutralizing Antibodies
Chlorides
Atherosclerosis
Membrane Proteins
Up-Regulation
Messenger RNA

Keywords

  • Atherosclerosis
  • Coronary disease
  • Endotoxins
  • MAP kinase
  • Signal transduction

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

TLR4-NOX4-AP-1 signaling mediates lipopolysaccharide-induced CXCR6 expression in human aortic smooth muscle cells. / Patel, Devang N.; Bailey, Steven R; Gresham, John K.; Schuchman, David B.; Shelhamer, James H.; Goldstein, Barry J.; Foxwell, Brian M.; Stemerman, Michael B.; Maranchie, Jodi K.; Valente, Anthony J.; Mummidi, Srinivas; Chandrasekar, Bysani.

In: Biochemical and Biophysical Research Communications, Vol. 347, No. 4, 08.09.2006, p. 1113-1120.

Research output: Contribution to journalArticle

Patel, DN, Bailey, SR, Gresham, JK, Schuchman, DB, Shelhamer, JH, Goldstein, BJ, Foxwell, BM, Stemerman, MB, Maranchie, JK, Valente, AJ, Mummidi, S & Chandrasekar, B 2006, 'TLR4-NOX4-AP-1 signaling mediates lipopolysaccharide-induced CXCR6 expression in human aortic smooth muscle cells', Biochemical and Biophysical Research Communications, vol. 347, no. 4, pp. 1113-1120. https://doi.org/10.1016/j.bbrc.2006.07.015
Patel, Devang N. ; Bailey, Steven R ; Gresham, John K. ; Schuchman, David B. ; Shelhamer, James H. ; Goldstein, Barry J. ; Foxwell, Brian M. ; Stemerman, Michael B. ; Maranchie, Jodi K. ; Valente, Anthony J. ; Mummidi, Srinivas ; Chandrasekar, Bysani. / TLR4-NOX4-AP-1 signaling mediates lipopolysaccharide-induced CXCR6 expression in human aortic smooth muscle cells. In: Biochemical and Biophysical Research Communications. 2006 ; Vol. 347, No. 4. pp. 1113-1120.
@article{bfe5f68af41c487a810dfc21037d0976,
title = "TLR4-NOX4-AP-1 signaling mediates lipopolysaccharide-induced CXCR6 expression in human aortic smooth muscle cells",
abstract = "CXCL16 is a transmembrane non-ELR CXC chemokine that signals via CXCR6 to induce aortic smooth muscle cell (ASMC) proliferation. While bacterial lipopolysaccharide (LPS) has been shown to stimulate CXCL16 expression in SMC, its effects on CXCR6 are not known. Here, we demonstrate that LPS upregulates CXCR6 mRNA, protein, and surface expression in human ASMC. Inhibition of TLR4 with neutralizing antibodies or specific siRNA interference blocked LPS-mediated CXCR6 expression. LPS stimulated both AP-1 (c-Fos, c-Jun) and NF-κB (p50 and p65) activation, but only inhibition of AP-1 attenuated LPS-induced CXCR6 expression. Using dominant negative expression vectors and siRNA interference, we demonstrate that LPS induces AP-1 activation via MyD88, TRAF6, ERK1/2, and JNK signaling pathways. Furthermore, the flavoprotein inhibitor diphenyleniodonium chloride significantly attenuated LPS-mediated AP-1-dependent CXCR6 expression, as did inhibition of NOX4 NADPH oxidase by siRNA. Finally, CXCR6 knockdown inhibited CXCL16-induced ASMC proliferation. These results demonstrate that LPS-TLR4-NOX4-AP-1 signaling can induce CXCR6 expression in ASMC, and suggest that the CXCL16-CXCR6 axis may be an important proinflammatory pathway in the pathogenesis of atherosclerosis.",
keywords = "Atherosclerosis, Coronary disease, Endotoxins, MAP kinase, Signal transduction",
author = "Patel, {Devang N.} and Bailey, {Steven R} and Gresham, {John K.} and Schuchman, {David B.} and Shelhamer, {James H.} and Goldstein, {Barry J.} and Foxwell, {Brian M.} and Stemerman, {Michael B.} and Maranchie, {Jodi K.} and Valente, {Anthony J.} and Srinivas Mummidi and Bysani Chandrasekar",
year = "2006",
month = "9",
day = "8",
doi = "10.1016/j.bbrc.2006.07.015",
language = "English (US)",
volume = "347",
pages = "1113--1120",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "4",

}

TY - JOUR

T1 - TLR4-NOX4-AP-1 signaling mediates lipopolysaccharide-induced CXCR6 expression in human aortic smooth muscle cells

AU - Patel, Devang N.

AU - Bailey, Steven R

AU - Gresham, John K.

AU - Schuchman, David B.

AU - Shelhamer, James H.

AU - Goldstein, Barry J.

AU - Foxwell, Brian M.

AU - Stemerman, Michael B.

AU - Maranchie, Jodi K.

AU - Valente, Anthony J.

AU - Mummidi, Srinivas

AU - Chandrasekar, Bysani

PY - 2006/9/8

Y1 - 2006/9/8

N2 - CXCL16 is a transmembrane non-ELR CXC chemokine that signals via CXCR6 to induce aortic smooth muscle cell (ASMC) proliferation. While bacterial lipopolysaccharide (LPS) has been shown to stimulate CXCL16 expression in SMC, its effects on CXCR6 are not known. Here, we demonstrate that LPS upregulates CXCR6 mRNA, protein, and surface expression in human ASMC. Inhibition of TLR4 with neutralizing antibodies or specific siRNA interference blocked LPS-mediated CXCR6 expression. LPS stimulated both AP-1 (c-Fos, c-Jun) and NF-κB (p50 and p65) activation, but only inhibition of AP-1 attenuated LPS-induced CXCR6 expression. Using dominant negative expression vectors and siRNA interference, we demonstrate that LPS induces AP-1 activation via MyD88, TRAF6, ERK1/2, and JNK signaling pathways. Furthermore, the flavoprotein inhibitor diphenyleniodonium chloride significantly attenuated LPS-mediated AP-1-dependent CXCR6 expression, as did inhibition of NOX4 NADPH oxidase by siRNA. Finally, CXCR6 knockdown inhibited CXCL16-induced ASMC proliferation. These results demonstrate that LPS-TLR4-NOX4-AP-1 signaling can induce CXCR6 expression in ASMC, and suggest that the CXCL16-CXCR6 axis may be an important proinflammatory pathway in the pathogenesis of atherosclerosis.

AB - CXCL16 is a transmembrane non-ELR CXC chemokine that signals via CXCR6 to induce aortic smooth muscle cell (ASMC) proliferation. While bacterial lipopolysaccharide (LPS) has been shown to stimulate CXCL16 expression in SMC, its effects on CXCR6 are not known. Here, we demonstrate that LPS upregulates CXCR6 mRNA, protein, and surface expression in human ASMC. Inhibition of TLR4 with neutralizing antibodies or specific siRNA interference blocked LPS-mediated CXCR6 expression. LPS stimulated both AP-1 (c-Fos, c-Jun) and NF-κB (p50 and p65) activation, but only inhibition of AP-1 attenuated LPS-induced CXCR6 expression. Using dominant negative expression vectors and siRNA interference, we demonstrate that LPS induces AP-1 activation via MyD88, TRAF6, ERK1/2, and JNK signaling pathways. Furthermore, the flavoprotein inhibitor diphenyleniodonium chloride significantly attenuated LPS-mediated AP-1-dependent CXCR6 expression, as did inhibition of NOX4 NADPH oxidase by siRNA. Finally, CXCR6 knockdown inhibited CXCL16-induced ASMC proliferation. These results demonstrate that LPS-TLR4-NOX4-AP-1 signaling can induce CXCR6 expression in ASMC, and suggest that the CXCL16-CXCR6 axis may be an important proinflammatory pathway in the pathogenesis of atherosclerosis.

KW - Atherosclerosis

KW - Coronary disease

KW - Endotoxins

KW - MAP kinase

KW - Signal transduction

UR - http://www.scopus.com/inward/record.url?scp=33746324819&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746324819&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2006.07.015

DO - 10.1016/j.bbrc.2006.07.015

M3 - Article

C2 - 16870145

AN - SCOPUS:33746324819

VL - 347

SP - 1113

EP - 1120

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 4

ER -